Senti Biosciences (SNTI) News Today → Pentagon contract could send this $2 AI stock soaring (From Behind the Markets) (Ad) Free SNTI Stock Alerts $0.28 -0.02 (-6.65%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSenti Biosciences (NASDAQ:SNTI) Shares Down 8.7% americanbankingnews.com - April 23 at 3:00 AMSenti Biosciences, Inc.: Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlightsfinanznachrichten.de - March 23 at 5:22 PMSenti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlightsglobenewswire.com - March 21 at 4:05 PMSenti Biosciences Stock (NASDAQ:SNTI), Guidance and Forecastbenzinga.com - February 4 at 7:36 PMSenti Biosciences, Inc.: Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Programfinanznachrichten.de - January 8 at 7:36 AMSenti Biosciences to Cut Workforce by 37% to Focus on Potential Cancer Treatmentmarketwatch.com - January 5 at 8:33 PMSenti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Programfinance.yahoo.com - January 5 at 8:33 PMWhy Is Blood Cancer Focused Senti Biosciences Stock Trading Higher Today?finance.yahoo.com - December 22 at 12:31 PMSenti Bio : FDA Clears IND Application For SENTI-202 For Treatment Of R/R Hematologic Malignanciesmarkets.businessinsider.com - December 22 at 7:31 AMSenti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemiafinance.yahoo.com - December 22 at 7:31 AMSenti Biosciences, Inc.: Senti Bio Announces Third Quarter 2023 Results and Pipeline Updatesfinanznachrichten.de - November 24 at 8:31 AMSenti Bio Announces Third Quarter 2023 Results and Pipeline Updatesfinance.yahoo.com - November 13 at 5:04 PMSenti Biosciences Inc SNTImorningstar.com - November 11 at 1:25 PMWhy Is Cell & Gene Therapy-Focused Senti Biosciences Stock Trading Higher Today?msn.com - November 7 at 1:54 PMWhy Is Ventyx Biosciences (VTYX) Stock Down 76% Today?msn.com - November 7 at 8:53 AMWhy Is Senti Biosciences (SNTI) Stock Up 140% Today?msn.com - November 7 at 8:53 AMSenti Bio Announces New Strategic Collaboration with Celest Therapeutics for Clinical Development of SENTI-301A in Chinafinance.yahoo.com - November 6 at 7:39 PMSenti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer Annual Meetingfinance.yahoo.com - October 31 at 1:59 PMGene and cell therapy startup GeneFab takes over Senti Biosciences' Alameda manufacturing facilitybizjournals.com - October 9 at 8:46 PMShanti Overseas India Ltd (SNTI)investing.com - September 27 at 6:28 PMSenti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer 2023 Meetingfinance.yahoo.com - September 27 at 1:28 PMSenti Bio to Participate in Upcoming Conferencesfinance.yahoo.com - September 26 at 7:41 PMChardan Capital Reiterates Senti Biosciences (SNTI) Buy Recommendationmsn.com - August 15 at 5:34 PMSenti Biosciences, Inc.: Senti Bio Announces Second Quarter 2023 Results and Pipeline Updatesfinanznachrichten.de - August 11 at 4:32 PMSenti Bio Announces Second Quarter 2023 Results and Pipeline Updatesfinance.yahoo.com - August 11 at 4:32 PMSenti Biosciences, Inc. (SNTI) Reports Q2 Loss, Misses Revenue Estimatesfinance.yahoo.com - August 11 at 4:32 PMSenti Bio Announces Closing of Transaction Leveraging its CMC Capabilities into a Cell and Gene Therapy Manufacturing Innovation Business Backed by Celadon Partnersfinance.yahoo.com - August 10 at 9:04 AMHere's Why Senti Biosciences (NASDAQ:SNTI) Must Use Its Cash Wiselyfinance.yahoo.com - June 5 at 12:42 PMChardan Capital Maintains Senti Biosciences (SNTI) Buy Recommendationmsn.com - May 11 at 11:56 PMSenti Bio Announces First Quarter 2023 Results and Pipeline Updatesfinance.yahoo.com - May 9 at 8:18 PMSenti Bio Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2023 Annual Meetingfinance.yahoo.com - May 2 at 7:58 PMSenti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR Meetingfinance.yahoo.com - April 17 at 10:11 AMSenti Bio to Participate in Upcoming Investor Conferencesfinance.yahoo.com - April 14 at 2:05 PMExpert Ratings for Senti Biosciencesmarkets.businessinsider.com - March 24 at 1:44 PMMorgan Stanley Reaffirms Their Hold Rating on Senti Biosciences (SNTI)markets.businessinsider.com - March 24 at 7:39 AMSenti Biosciences Stock (NASDAQ:SNTI), Dividendsbenzinga.com - March 24 at 1:50 AMSenti Biosciences, Inc.: Senti Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Reviews Recent Highlightsfinanznachrichten.de - March 23 at 9:40 AMSenti Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Reviews Recent Highlightsfinance.yahoo.com - March 22 at 10:02 PMSenti Bio Announces Three Preclinical Data Presentations from Gene Circuit-Enhanced CAR-NK Cell Oncology Pipeline at Annual AACR Meetingfinance.yahoo.com - March 14 at 7:46 PMInvestors in Senti Biosciences (NASDAQ:SNTI) have unfortunately lost 82% over the last yearfinance.yahoo.com - February 6 at 8:37 AMSenti Bio to Present at the SVB Securities Global Biopharma Conferencefinance.yahoo.com - February 1 at 7:54 PMChardan Capital Maintains Buy Rating for Senti Biosciences: Here's What You Need To Knowmsn.com - January 30 at 3:33 PMSenti Biosciences (NASDAQ:SNTI) Price Target Lowered to $8.00 at Chardan Capitalmarketbeat.com - January 27 at 4:19 PMSenti Biosciences Launches New Strategic Plan, Sees Cash Runway to 1Q 2024marketwatch.com - January 27 at 8:53 AMSenti Bio Announces Pipeline Prioritization to Focus on Logic Gated Cell Therapies; Updates Cash Runway Guidancefinance.yahoo.com - January 27 at 8:53 AMWe Think Senti Biosciences (NASDAQ:SNTI) Needs To Drive Business Growth Carefullyfinance.yahoo.com - December 27 at 7:48 AMSenti Bio to Present at 41st Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - December 19 at 8:33 AMSenti Bio Highlights Preclinical Data from Logic-Gated Gene Circuit CAR-NK Cell Therapy SENTI-202 at ASH Annual Meeting and Investor Eventfinance.yahoo.com - December 11 at 11:10 AMSenti Biosciences, Inc. to Post FY2022 Earnings of ($1.38) Per Share, Chardan Capital Forecasts (NASDAQ:SNTI)marketbeat.com - November 17 at 7:52 AMSenti Biosciences Third Quarter 2022 Earnings: Beats Expectationsfinance.yahoo.com - November 16 at 6:36 PM Get Senti Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SNTI and its competitors with MarketBeat's FREE daily newsletter. Email Address Pentagon contract could send this $2 AI stock soaring (Ad)Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai... Get all the info here >>> SNTI Media Mentions By Week SNTI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNTI News Sentiment▼0.670.43▲Average Medical News Sentiment SNTI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNTI Articles This Week▼10▲SNTI Articles Average Week Get Senti Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SNTI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Inhibikase Therapeutics News Coeptis Therapeutics News Sorrento Therapeutics News Genetic Technologies News Organovo News BioCardia News Surrozen News Aptose Biosciences News Creative Medical Technology News Titan Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNTI) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressPentagon contract could send this $2 AI stock soaringBehind the MarketsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senti Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
